|
KMID : 0366220080430030184
|
|
Korean Journal of Hematology
2008 Volume.43 No. 3 p.184 ~ p.189
|
|
|
A Case of Atypical CML with Micro BCR/ABL Rearrangement
|
|
Kim Ji-Hae
Lee Won-Mok
Ryoo Nam-Hee
Ha Jung-Sook
Jeon Dong-Suk
Kim Jae-Ryong
Kwon Ki-Young
|
|
|
Abstract
|
|
|
Microtype BCR/ABL rearrangement is extremely rare and has been known to be associated with neutrophilic chronic myeloid leukemia (N-CML). However, there is more to be understood regarding this phenotype. We report a case of atypical CML that exhibited micro BCR/ABL rearrangement with predominant thrombocytosis. Our patient showed thrombocytosis (1,464×109/L) and megakaryocytosis in the peripheral blood and bone marrow. However, neither leukocytosis nor neutrophilia was observed (white blood cells (WBC), 5.02×109/L neutrophils, 45%). Bone marrow aspirate revealed increased cellularity: 12% basophils, 6% eosinophils, and 9% blasts. The 46,XX,t(9;22)(q34;q11.2),i(17q) chromosome complement was observed in 4 of 20 metaphase cells, and standard BCR/ABL fusion signals were observed
in 10% of interphase cells on fluorescence in situ-hybridization (FISH) analysis. Reverse transcriptasepolymerase chain reaction (RT-PCR) was used to acquire the BCR/ABL fusion transcript, the identity of which was confirmed via sequence analysis. Hematologic remission was achieved 2 months after imatinib therapy initiation, and molecular remission was achieved 2 months after hematologic remission. The patient is currently undergoing regular follow-up visits and is in good health. However, further long-term follow up is warranted. The incorporation of imatinib into therapeutic strategies may be further established through the study of more cases of micro BCR/ABL.
|
|
|
KEYWORD
|
|
|
Atypical CML, Micro BCR/ABL, ET, Imatinib
|
|
|
FullTexts / Linksout information
|
|
  
|
|
|
Listed journal information
|
|
  
|
|